Feb, 02 2024

了解視神經炎：病因、症狀、診斷、治療及其對視力和健康的影響

視神經炎是視神經的炎症，會擾亂眼睛和大腦之間的溝通。它通常與多發性硬化症等自體免疫疾病有關，也可能由感染或特發性原因引起。症狀包括視力喪失、視力模糊、眼球運動時疼痛和色覺問題。診斷包括眼科檢查和影像學檢查。治療通常包括使用皮質類固醇來減輕發炎。雖然大多數病例會隨著時間推移而痊癒，但視神經炎可能會留下殘留的視力障礙。定期接受醫療保健專業人員的追蹤對於控制病情和解決根本原因、確保最佳視力和整體健康至關重要。

訪問完整報告@ https://www.databridgemarketresearch.com/reports/us-optic-neuritis-market

Data Bridge Market Research 分析稱，美國視神經炎市場規模在 2021 年為 415 萬美元，預計到 2029 年將達到 611 萬美元，預計在 2022 年至 2029 年的預測期內複合年增長率為 5.0%。人口老化日益加劇，導致視神經炎盛行率不斷上升。隨著人口老化，這種疾病的發病率上升，擴大了患者群體並刺激了市場成長。

研究的主要發現

以患者為中心的方法 預計將推動市場成長率

視神經炎市場以患者為中心的方法優先考慮客製化治療方案以滿足個別患者的需求和偏好。這種對個人化護理的重視促進了更多患者友善療法的開發，從而促進了市場需求的成長。該行業透過使治療與患者的期望和舒適度相結合來解決醫療問題。它促進了患者的整體和積極的體驗，最終促進了視神經炎相關產品和服務的成長和成功。

報告範圍和市場細分

報告指標

細節

預測期

2022年至2029年

基準年

2021

歷史歲月

2020（可自訂為2014-2019）

定量單位

收入（百萬美元）、銷售（單位）、定價（美元）

涵蓋的領域

治療（皮質類固醇、靜脈注射免疫球蛋白、補充劑等）、診斷（MRI 掃描、腰椎穿刺、眼部相干斷層掃描、血液檢查等）、給藥途徑（腸外和口服）、最終用戶（醫院、診所、學術和研究機構等）、分銷渠道（醫院藥房、零售藥房等）

涵蓋的市場參與者

AbbVie Inc.（美國）、Bausch & Lomb Incorporated（美國）、Boehringer Ingelheim International GmbH（德國）、Novartis AG（瑞士）、Merck & Co., Inc.（美國）、Hikma Pharmaceuticals PLC（約旦）、Fresenius Kabi USA（德國）、Teva Ltds Ltds（德國）、GS plc（葛蘭素史克）（英國）、輝瑞（美國）、Akorn Operating Company LLC U（美國）、AdvaCare Pharma（美國）、Bristol-Myers Squibb Company（美國）、Jubilant Cadista Pharmaceuticals Inc.（美國）、Amneal Pharmaceuticals LLC。（美國）、Viatris Inc.（美國）、Novitium Pharma（美國）、Accure Therapeutics（美國）、Noveome Biotherapeutics, Inc.（美國）、Biogen（美國）、Mallinckrodt（英國）、Acorda Therapeutics（美國）、Sanofi（法國）等

報告涵蓋的數據點

除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括深度專家分析、患者流行病學、管道分析、定價分析和監管框架。

細分分析：

美國視神經炎市場根據治療、診斷、給藥途徑、最終用戶和分銷管道進行細分。

根據治療類型，美國視神經炎市場細分為皮質類固醇、靜脈注射免疫球蛋白、補充劑和其他

根據診斷，美國視神經炎市場細分為 MRI 掃描、腰椎穿刺、眼相干斷層掃描、血液檢查等

根據給藥途徑，美國視神經炎市場分為腸外給藥和口服給藥

根據最終用戶，美國視神經炎市場分為醫院、診所、學術和研究機構等

根據分銷管道，美國視神經炎市場分為醫院藥房、零售藥房和其他

主要參與者

Data Bridge Market Research 認為以下公司是美國視神經炎市場的主要參與者，它們是 AbbVie Inc.（美國）、Bausch & Lomb Incorporated（美國）、Boehringer Ingelheim International GmbH（德國）、Novartis AG（瑞士）、Merck & Co., Inc.（美國）、Hikma Pharmaceuticals PLC（約旦）

市場發展

2022 年 10 月，Trethera 獲得了一筆 160 萬美元的巨額資助，用於推進 TRE-515 的開發，使其成為治療視神經炎（多發性硬化症 (MS) 的常見症狀）的潛在療法。這項資助強調了探索視神經炎創新解決方案的承諾，為加強治療和改善療效帶來了希望，特別是在多發性硬化症相關併發症的背景下

2022年8月，美國FDA授予Trethera Corporation用於治療脫髓鞘性視神經炎的口服療法TRE-515孤兒藥物地位。這種實驗性治療方法有望治療視神經炎，視神經炎可能發展為多發性硬化症或在其進展過程中表現出來。孤兒藥資格認定認可了 TRE-515 在治療這種威脅視力的疾病方面滿足未滿足醫療需求的潛力

2022 年 6 月，勃林格殷格翰有限公司獲得了 Trutino Biosciences Inc. 的收購選擇權，這是一家位於聖地亞哥的生物技術公司，專門從事多種疾病治療的臨床前階段研究。這項策略性舉措增強了勃林格殷格翰的全球影響力，拓寬了其產品線，使公司在競爭激烈的生物製藥市場中保持成長和創新

2021 年 9 月，諾華公司收購了 Arctos Medical，以擴大其光遺傳學產品組合，旨在為視力嚴重受損的個人提供基因治療。這項策略性措施彰顯了諾華致力於開拓創新治療和追求治療成功的承諾。此次收購鞏固了該公司在開發嚴重視力喪失創新解決方案方面的地位，符合其透過尖端治療方法改善患者治療效果的使命

有關美國視神經炎市場報告的更多詳細信息，請點擊此處 - https://www.databridgemarketresearch.com/reports/us-optic-neuritis-market

CHOOSE LICENCE TYPE

Enterprise User 7000
Single User 4800
DBMR Factbook 3000
DBMR Prime 8000
DBMR Nucleus 12000

Buy Now

Advance Formative Research Customization Request for bulk Reports

Latest Press Release

Expanding FPC Adoption in Automotive and Medical Electronics is Expected to Drive the Market

Rising Prevalence of Chronic Diseases is the Driving Factor in the Market

Growing Focus on Nuclear Fusion Research Drives Soft Magnetic Material Demand

Growing Demand for Packaged Beverages, Pharmaceuticals, and Personal Care Products

Rising Demand for Packaged and Convenience Food Products, Supported by Rapid Urbanization and Lifestyle Changes, is Driving the Growth of the Global Flexible Packaging Market

Rising Demand for Antioxidants in Processed Food and Beverages is the Driving Factor in the Market

VIEW ALL

Client Testimonials

Claudio Rondena

Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL

"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."

David Manning - Thermo Fisher Scientific

Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Manager - Market Analytics,

Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,

(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Business Intelligence and Analytics,

Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst,

Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director,

Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,

A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director,

Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager,

Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations,

GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst,

Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager,

Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment

MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer

Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro

Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)

UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future